Irreversible corneal decompensation in patients treated with topical dorzolamide
- 30 April 1999
- journal article
- case report
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 127 (4) , 403-406
- https://doi.org/10.1016/s0002-9394(98)00438-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Double-Masked, Randomized, 1-Year Study Comparing the Corneal Effects of Dorzolamide, Timolol, and BetaxololArchives of Ophthalmology (1950), 1998
- Corneal Endothelium Five Years After TransplantationAmerican Journal of Ophthalmology, 1994
- Four-Week Safety and Efficacy Study of Dorzolamide, a Novel, Active Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1993
- Novel Topical Thiadiazoles and Benzothiazoles as Pharmacological Probes of Corneal Endothelial FunctionJournal of Ocular Pharmacology and Therapeutics, 1993
- Dose Response and Duration of Action of Dorzolamide, a Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1992
- MK-507 (L-671,152), a Topically Active Carbonic Anhydrase Inhibitor, Reduces Aqueous Humor Production in MonkeysArchives of Ophthalmology (1950), 1991
- The Effect of Allograft Rejection After Penetrating Keratoplasty on Central Endothelial Cell DensityAmerican Journal of Ophthalmology, 1991
- MK-507 versus SezolamideOphthalmology, 1991
- Endothelial cell loss after phacoemulsification and insertion of silicone lens implantsJournal of Cataract & Refractive Surgery, 1987
- Long-term Morphologic Changes in the Endothelium of Transplanted CorneasArchives of Ophthalmology (1950), 1985